Northern New England Clinical and Translational Research Network - N3C Initiative

NIH Pandemic-Era Grants

Pandemic Era Grants

2023

↗ Live URL (may be dead)

Document text

Principal Investigator: CLIFFORD JAMES ROSEN
Organization: MAINEHEALTH
Fiscal Year: 2023
Award: $348,252
Funding agency: National Institute of General Medical Sciences

ABSTRACT
The National Covid Cohort Collaborative (N3C), sponsored by the National Center for Advancing Translational
Sciences (NCATS) and the National Center for Data to Health (Cd2H) have created a centralized national
database on a cloud-based analytic platform for scientists to use to study COVID-19, identify potential
treatments, and report on outcomes and health disparities. It is a partnership among more than 80 institutions
that is funded by the National Institutes of Health. Collaborators have contributed data so far on nearly 8 million
COVID-19 positive patients, as well as several million control patients. The collaborators use the clinical data
on these patients to answer critical research questions to address the pandemic and accelerate development
of effective treatments. The Northern New England Clinical and Translational Research Network has actively
participated in N3C for over 3 years and is submitting this administrative supplement to allow for our continued
participation for another year. This application details our past accomplishments and describes our planned
work for the coming year.

Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><65+ years old><AI system><Acceleration><Address><Administrative Supplement><Aged 65 and Over><Area><Artificial Intelligence><Big Data><BigData><COVID crisis><COVID epidemic><COVID infected patient><COVID pandemic><COVID patient><COVID positive patient><COVID-19><COVID-19 affected><COVID-19 consequence><COVID-19 crisis><COVID-19 effect><COVID-19 epidemic><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 impact><COVID-19 impacted><COVID-19 infected patient><COVID-19 pandemic><COVID-19 patient><COVID-19 positive patient><COVID-19 public health crisis><COVID-19 therapy><COVID-19 treatment><COVID-19 virus><COVID19><COVID19 crisis><COVID19 epidemic><COVID19 global health crisis><COVID19 global pandemic><COVID19 health crisis><COVID19 pandemic><COVID19 patient><COVID19 positive patient><COVID19 public health crisis><COVID19 therapy><COVID19 treatment><COVID19 virus><CV-19><CV19><Cancers><Cardiovascular Diseases><Clinical Data><Clinical Research><Clinical Study><CoV-2><CoV2><Collaborations><Communities><Community Health><Computer Reasoning><Contracting Opportunities><Contracts><Coupled><Cultural Diversity><Data><Data Bases><Databases><Dedications><Deposit><Deposition><Development><Diabetes Mellitus><Disease><Disorder><Education><Education and Outreach><Education and Training><Educational Activities><Educational aspects><Food><Funding><Goals><Health><Immigrant><Infrastructure><Institution><Instruction and Outreach><Investigators><Leadership><Link><Machine Intelligence><Machine Learning><Maine><Malignant Neoplasms><Malignant Tumor><Manuscripts><Minority><Multiculturalism><NCATS><NIGMS><NIH><NIH RFA><National Center for Advancing Translational Sciences><National Institute of General Medical Sciences><National Institutes of Health><Native Americans><New England><New Hampshire><Northeastern United States><Obesity><Patients><Population><Refugees><Registries><Reporting><Request for Applications><Research><Research Infrastructure><Research Personnel><Research Resources><Researchers><Resources><Rural><Rural Health><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 infected patient><SARS-CoV-2 pandemic><SARS-CoV-2 patient><SARS-CoV-2 positive patient><SARS-CoV-2 therapy><SARS-CoV-2 treatment><SARS-CoV2><SARS-CoV2 epidemic><SARS-CoV2 pandemic><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Sampling><Science><Scientist><Secure><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome related corona virus 2><Substance Use Disorder><System><Techniques><Training and Education><Training and Outreach><Translational Research><Translational Science><Tribes><Tutoring and Outreach><Underserved Population><United States National Institutes of Health><Universities><Variant><Variation><Vermont><Viral><Work><Wuhan coronavirus><adiposity><age 65 and greater><age 65 and older><aged 65 and greater><aged ≥65><cardiovascular disorder><cloud based><cohort><community based design><community based research><community-based health><computational infrastructure><computer infrastructure><corona virus disease 2019><corona virus disease 2019 epidemic><corona virus disease 2019 pandemic><coronavirus disease 2019><coronavirus disease 2019 consequence><coronavirus disease 2019 crisis><coronavirus disease 2019 effect><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 impact><coronavirus disease 2019 infected patient><coronavirus disease 2019 pandemic><coronavirus disease 2019 patient><coronavirus disease 2019 positive patient><coronavirus disease 2019 public health crisis><coronavirus disease 2019 therapy><coronavirus disease 2019 treatment><coronavirus disease 2019 virus><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease infected patient><coronavirus disease pandemic><coronavirus disease patient><coronavirus disease positive patient><coronavirus disease-19><coronavirus disease-19 global pandemic><coronavirus disease-19 impact><coronavirus disease-19 pandemic><coronavirus disease-19 patient><coronavirus disease-19 virus><coronavirus infectious disease-19><coronavirus patient><corpulence><data base><data infrastructure><data registry><data warehouse><developmental><diabetes><disparate effect><disparate impact><disparate result><disparity in health><effective therapy><effective treatment><experience><hCoV19><health disparity><human old age (65+)><improved><inequitable effect><inequitable impact><inequitable outcome><innovate><innovation><innovative><interest><investigator training><machine based learning><malignancy><member><nCoV2><neoplasm/cancer><old age><operation><operations><outcome disparities><outcome inequality><outcome inequity><pandemic><pandemic disease><patient infected with COVID><patient infected with COVID-19><patient infected with SARS-CoV-2><patient infected with coronavirus disease><patient infected with coronavirus disease 2019><patient infected with severe acute respiratory syndrome coronavirus 2><patient with COVID><patient with COVID-19><patient with COVID19><patient with SARS-CoV-2><patient with coronavirus disease><patient with coronavirus disease 2019><patient with severe acute respiratory distress syndrome coronavirus 2><practice-based research network><primary care practice><rural dwellers><rural resident><rurality><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><severe acute respiratory syndrome coronavirus 2 infected patient><severe acute respiratory syndrome coronavirus 2 patient><severe acute respiratory syndrome coronavirus 2 positive patient><severe acute respiratory syndrome coronavirus 2 therapy><severe acute respiratory syndrome coronavirus 2 treatment><substance use and disorder><translation research><translational investigation><treat COVID-19><treat COVID19><treat SARS-CoV-2><treat coronavirus disease 2019><treat severe acute respiratory syndrome coronavirus 2><under served group><under served individual><under served people><under served population><underserved group><underserved individual><underserved people><unequal effect><unequal impact><unequal outcome>